BioNTech SE Cost Of Inventories Recognised As Expense During Period
BioNTech SE (BNTX) reported Cost Of Inventories Recognised As Expense During Period of EUR 189.30 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Expense Statement › Cost of Sales
ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod · last filed 2026-03-10
| Period end | Cost Of Inventories Recognised As Expense During Period 12 month |
|---|---|
| 2025-12-31 | 189.30M EUR 20-F · filed 2026-03-10 |
| 2024-12-31 | 129.50M EUR 20-F · filed 2026-03-10 |
| 2023-12-31 | 354.40M EUR 20-F · filed 2025-03-10 |
| 2022-12-31 | 1.55B EUR 20-F · filed 2024-03-20 |
| 2021-12-31 | 1.26B EUR 20-F · filed 2023-03-27 |
| 2020-12-31 | 32.10M EUR 20-F/A · filed 2022-10-26 |
| 2019-12-31 | 2.18M EUR 20-F · filed 2020-03-31 |
| 2018-12-31 | 1.79M EUR 20-F · filed 2020-03-31 |